Zhaoke eyes $270m from Hong Kong IPO

Hong Kong_flag_adobe_12May_575
By Rashmi Kumar
16 Apr 2021

Chinese company Zhaoke Ophthalmology has kicked off a Hong Kong IPO worth up to HK$2.1bn ($270m), becoming the latest biotechnology company to sell shares on the bourse.

Bookbuilding started on Friday morning, with the issuer offering investors about 123.6m primary shares in the base offer. There is a greenshoe option equal to 15% of the base deal, as is standard with Hong Kong IPOs, or up to 18.5m shares.

Zhaoke is wooing investors to a ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial